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Summary
Objective: To determine the effects of osteoarthritic (OA) subchondral osteoblasts on the metabolism of human OA chondrocytes
in alginate beads.
Methods: Human chondrocytes were isolated from OA cartilage and cultured in alginate beads for 4 days in the absence or in the presence
of osteoblasts isolated from non-sclerotic (N) or sclerotic (SC) zones of human OA subchondral bone in monolayer (co-culture system). Before
co-culture, osteoblasts were incubated for 72 h with or without 1.7 ng/ml interleukin (IL)-1b, 100 ng/ml IL-6 with its soluble receptor (50 ng/ml)
or 10 ng/ml oncostatin M (OSM). Aggrecan (AGG) and matrix metalloproteases (MMP)-3 and -13 mRNA levels in chondrocytes were
quantiﬁed by real-time polymerase chain reaction. AGG production was assayed by a speciﬁc enzyme ampliﬁed sensitivity immunoassay.
Results: SC, but not N, osteoblasts induced a signiﬁcant inhibition of AGG production and AGG gene expression by human OA chondrocytes
in alginate beads, and signiﬁcantly increased MMP-3 and MMP-13 gene expression by chondrocytes. When they were pre-incubated with
IL-1b, IL-6 or OSM, N osteoblasts inhibited AGG synthesis and increased MMP-3 and -13 gene expression by chondrocytes in alginate beads
in a same order of magnitude as SC osteoblasts.
Conclusions: These results demonstrate that SC OA subchondral osteoblasts could contribute to cartilage degradation by stimulating
chondrocytes to produce more MMP and also by inhibiting AGG synthesis.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyThere is consensus that osteoarthritis (OA) is characterized
by subchondral bone thickening, accompanied by an
increased osteoid volume and a low mineralization1. These
histomorphological modiﬁcations indicate that a dysregula-
tion of bone remodeling may be part of OA. Indeed,
osteoblasts isolated from subchondral OA bone demon-
strate an altered phenotype2. In comparison to normal
osteoblasts, they produce more alkaline phosphatase
(ALP), osteocalcin (OC), insulin-like growth factor (IGF)-1
and urokinase (uPA), while IGF-binding protein (IGFBP)
and plasminogen activator inhibitor (PAI)-1 levels remain
unchanged3,4. The imbalance between PAI-1 and uPA may
favor the hydrolysis of IGFBP, resulting in the freeing of
IGF-1 locally, which can then act via an autocrine/paracrine
pathway to enhance bone matrix formation2. Further, OA
osteoblasts are resistant to parathyroid hormone (PTH)
stimulation, a situation that can also contribute to abnormal
bone remodeling and bone sclerosis in OA3. Based on the
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Received 13 October 2004; revision accepted 14 March 2005.97production of interleukin (IL)-6 and prostaglandin (PG) E2,
two groups of OA individuals have been identiﬁed.
Osteoblasts from one group of individuals produced levels
of PGE2 and IL-6 very similar to normal cells, whereas
another group of OA individuals always showed an
increased PGE2 and IL-6 production
5. Interestingly, all OA
osteoblasts produce higher level of transforming growth
factor (TGF)-b1 compared to normal cells, whereas IL-1b
production is similar5. Because microcracks, vascular
channels or neovascularization provide a link between
subchondral bone tissue and cartilage, it was hypothesized
that IL-6, TGF-b and probably some other unexplored
factors could also contribute to the abnormal remodeling of
OA cartilage6e9. Westacott et al.10 have shown that OA
osteoblasts in monolayer increased glycosaminoglycan
release from cartilage explants, whereas normal cells did
not. However, no single effector responsible for osteoblast-
induced cartilage degradation has been yet identiﬁed.
Until now, the inﬂuence of OA osteoblasts phenotype on
cartilage matrix formation and metalloproteinases synthesis
remains unexplored. Herein, we describe an original co-
culture model in which osteoblasts in monolayer, isolated
from non-sclerotic (N) or sclerotic (SC) zones of human
subchondral bone, are cultured together with OA human9
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chondrocytes with N or SC osteoblasts pre-incubated with
IL-1b, -6 or oncostatin M (OSM). These cytokines play an
important role in bone remodeling and could be involved in
bone sclerosis process that occurs in OA. IL-6, in the
presence of its soluble receptor (IL-6sR), increases
collagenase-3 and IGF-1 expression in osteoblasts from
fetal rat calvariae11,12. IL-6 also stimulates bone resorption
by increasing osteoclasts recruitment and differentiation.
The effects of IL-6 on osteoclasts recruitment require the
presence of osteoblasts and depend on IL-6 receptors and
receptor activator of NF-kB (RANK)/RANK ligand13. In
primary neonatal murine or fetal rat calvariae osteoblasts
culture, OSM induces proliferation, collagen synthesis, and
IL-6 secretion, whereas it inhibits ALP14. In primary culture
of rat osteoblast cells, IL-1b decreases OC synthesis but
has no effect on ALP activity15. IL-1b also stimulates PTH-
related protein, PGE2, IL-6 and plasminogen activator
secretion and decreases TGF-b1 production by human
osteoblast-like cells16e18.
In this work, we demonstrate that SC OA osteoblasts
phenotype contributes to cartilage degradation by inhibiting
cartilage matrix component synthesis and by increasing
metalloproteinases synthesis by human chondrocytes.
Further, we show that N osteoblasts incubated with IL-1b,
IL-6 and OSM have similar effect to that of SC osteoblasts
on chondrocytes in alginate beads. These ﬁndings suggest
that these cytokines could be responsible for the modiﬁca-
tions of osteoblasts phenotype in OA.
Materials and methods
SUBCHONDRAL OA OSTEOBLASTS IN MONOLAYER CULTURE
Tibial and femoral subchondral bone plates were
collected from the knees of cadavers (three men aged 48,
57 and 65 years) with severe OA within 2 h after death.
After careful elimination of trabecular bone and articular
cartilage, OA subchondral bone was dissected under
a microscope to separate SC from N zones. N and OA
SC bone zones were identiﬁed by a marked difference in
thickness and intermediate zones were not used. We have
considered as SC bone only the subchondral bone zone
with a thickness greater than 2 mm and either cartilage
denuded or overlaid by ﬁbrillated cartilage. The plates were
then cut into small fragments of approximately 2 mm3 with
wire cutters, washed with Dulbecco’s Modiﬁed Eagle
Medium (DMEM) and then submitted to enzymatic diges-
tions following the protocol of Hilal et al.2. Brieﬂy, small
pieces of bone (2 mm3) were sequentially incubated with
0.5 mg/ml hyaluronidase type IV S (SigmaeAldrich, Bor-
nem, Belgium) for 20 min, and 0.6 mg/ml clostridial colla-
genase IA (SigmaeAldrich, Bornem, Belgium) for 30 and
240 min successively (2 g of bone in 20 ml of enzymatic
solution). The digested bone pieces were placed in T-75
ﬂasks and cultured in DMEM supplemented with 15% fetal
calf serum (FCS), 10 mM HEPES, 100 U/ml penicillin and
100 mg/ml streptomycin, until osteoblasts migrated out of
bone explants. At this point, the medium was replaced with
fresh media containing 10% FCS, 10 mM HEPES, 100 U/ml
penicillin and 100 mg/ml streptomycin. At conﬂuence, cells
were collected by trypsinization, seeded (50,000 cells/cm2)
in 12-well plates (12-well companion plates, Falcon, BD
Biosciences, Erembodegem, Belgium) and grown for 3
days in DMEM containing 10% FCS, 100 U/ml penicillin,
100 mg/ml streptomycin, 10 mM HEPES. After washings,osteoblasts were maintained for 12 days in differentiation
media, composed of DMEM containing 100 U/ml penicillin,
100 mg/ml streptomycin, 10 mM HEPES, 2% Ultroser G,
a serum substitute, 108 M 1,25(OH)2vitamin D3 (Sig-
maeAldrich, Bornem, Belgium), 50 mg/ml ascorbic acid
(SigmaeAldrich, Bornem, Belgium) and 2 mM proline
(Invitrogen, Merelbeke, Belgium). At the end of this
differentiation period, cells showed an osteoblastic pheno-
type characterized by the production of OC and ALP. The
cell population was homogenous and did not contain
ﬁbroblastic or adipocytic cell types as shown by morpho-
logical observations and Fast Red or Oil Red O staining.
N osteoblasts were isolated from normal areas of sub-
chondral bone whereas SC osteoblasts were isolated from
the SC areas of subchondral bone. After washings, cells
were then cultured for 72 h in the absence or in
the presence of human recombinant IL-1b (1.7 ng/ml or
85 U/ml, Roche, Brussels, Belgium), 100 ng/ml IL-6 in
combination with 50 ng/ml IL-6sR (Biosource Europe,
Fleurus, Belgium) or 10 ng/ml OSM (SigmaeAldrich, Bor-
nem, Belgium). These concentrations corresponded to the
maximal IL-1b, OSM and IL-6 concentrations found in the
synovial ﬂuid of OA patients19e21. The nutrient medium
used in this incubation phase was DMEM supplemented
with 1% ITSC (ICN Biomedicals, Asse-Relegem, Belgium),
10 mM HEPES, 100 U/ml penicillin, 100 mg/ml streptomycin,
50 mg/ml ascorbic acid (SigmaeAldrich, Bornem, Belgium),
2 mM proline (Invitrogen, Merelbeke, Belgium). ITSC is
a premixed cell growth system containing in 1 ml: 0.625 mg
insulin, 0.625 mg transferrin, 0.625 mg selenious acid,
0.125 g bovine serum albumin and 0.535 mg linoleic acid.
CHONDROCYTES CULTURE IN ALGINATE BEADS
Cartilage was obtained from the knees of cadavers (three
men aged 50, 52 and 63 years) with OA within the 2 h after
death, being excised from the superﬁcial and medium
layers of cartilage and avoiding the calciﬁed layer. Upon
dissection, the femoral, patellar and tibial articular surfaces
were evaluated for gross pathological cartilage modiﬁca-
tions according to a personal scale22. The severity of pitting
was recorded for each donor. Four different grades were
considered: 0, normal white cartilage in all areas examined;
I, the presence of a yellowegray area with some superﬁcial
ﬁbrillations on one or more articular surfaces; II, irregular
surface with deep ﬁbrillations on one or more articular
surfaces; and III, ulcers penetrating to the subchondral
bone on one or more articular surfaces. Experiments were
performed with cartilage specimen showing OA cartilage
lesions of grade II or III. Cartilage was cut into small
fragments and then subjected to enzymatic digestions
sequentially with hyaluronidase, pronase and collagenase
(3 g of cartilage per 10 ml of enzyme solution) as previously
described23. The cells were ﬁltered through a nylon mesh
with a pore diameter of 70 mm, and then washed three times
with sterile water (0.9% NaCl). Cell viability was estimated
by trypan blue exclusion test and in all cases was greater
than 95%. Chondrocytes were suspended in 1.2% low
viscosity alginate (SigmaeAldrich, Bornem, Belgium) in
0.9% NaCl solution at a density of 4! 106 cells/ml, which
was slowly passed through a 25 gauge needle in a dropwise
fashion into 102 mM CaCl2 solution (SigmaeAldrich,
Bornem, Belgium). After instantaneous gelation, the beads
were allowed to polymerize further for 10 min in this CaCl2
solution. Ten alginate beads containing OA chondrocytes
were placed in porous inserts (with 1 mm pore size; Falcon,
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a nutrient culture medium (DMEM supplemented with 2%
Ultroser G) for the next 48 h (wash-out period). Then, the
beads were washed in phosphate buffered saline (PBS)
and placed in co-culture with N or SC OA subchondral
osteoblasts or with normal skin ﬁbroblasts in monolayer.
Normal skin ﬁbroblasts obtained by outgrowh from biopsy
as previously described24 were provided by Lambert Ch
(Lie`ge, Belgium).
OA OSTEOBLASTS/CHONDROCYTES CO-CULTURE
After three PBS washes of osteoblasts or alginate beads,
the inserts (with a pore size of 1 mm; Falcon, BD
Biosciences, Erembodegem, Belgium) containing 10 algi-
nate beads were co-cultured for 4 days with osteoblasts in
monolayer pre-incubated or not with cytokines (Fig. 1). Co-
culture medium was DMEM supplemented with 1% ITSC,
10 mM HEPES, 100 U/ml penicillin, 100 mg/ml streptomy-
cin, 50 mg/ml ascorbic acid, 2 mM proline. Six wells of a 12-
well plate were used for each culture conditions. The
experiment was repeated three times, each time using
subchondral osteoblasts and chondrocytes coming from
different donors, and six wells were used for each culture
condition. As controls, OA chondrocytes in alginate beads
were cultured in mono-culture or in co-culture with normal
skin ﬁbroblasts in monolayer. At the end of the co-culture
period, cells conditioned culture medium (S) was carefully
collected and kept at 20(C until analysis. The alginate
beads were dissolved in 1 ml of 0.1 M citrate for 10 min. The
resulting suspension was centrifuged at 1200 rpm for
10 min. By this method, two fractions were collected: the
supernatant containing macromolecules originated from the
further-removed matrix (FRM) compartment, and a pellet,
containing cells with their associated matrix (CM). Osteo-
blasts in monolayer were collected after 5 min treatment
with a solution containing 0.125% trypsine0.5 mM EDTA
(Invitrogen, Merelbeke, Belgium). The cell pellets of
chondrocytes, osteoblasts or ﬁbroblasts were washed three
times with PBS and then either homogenized in 1 ml PBS
by ultrasonic dissociation for DNA and aggrecan (AGG)
quantiﬁcation or in 175 ml of cell lysis buffer (Promega,
Leiden, The Netherlands) for RNA isolation. Cell extracts
were kept at 70(C until analysis.
DNA ASSAY
The DNA content of the cultures was measured accord-
ing to the ﬂuorimetric method of Labarca and Paigen25.
IMMUNOASSAYS FOR AGG, MMP-3, OC, IL-1b, IL-6 AND TGF-b1
AGG, matrix metalloprotease (MMP)-3, OC, IL-1b, IL-6
and TGF-b1 were directly measured in conditioned culture
Fig. 1. Schematic representation of the subchondral osteoblasts/
chondrocytes co-culture model.media by speciﬁc enzyme ampliﬁed sensitivity immuno-
assays (EASIA, Biosource Europe, Fleurus, Belgium26).
AGG was measured in the different compartments of
alginate bead and in culture supernatants by a speciﬁc
EASIA in which a monoclonal antibody raised against the
keratan sulphate region of AGG as a capture antibody, and
another monoclonal antibody recognizes the hyaluronic
acid binding region (HABR) as a detector. The AGG HABR
is captured by the anti-KS antibody irrespective of whether
cytokine-induced proteolysis occurs in the AGG interglob-
ular domain, so permitting accurate quantiﬁcation of AGG
synthesis. Human puriﬁed AGG was used as standard to
quantiﬁcation. The limit of detection of these immunoassays
was 5.5 ng/ml for AGG, 1.25 ng/ml for MMP-3, 1.9 ng/ml for
OC, 10 pg/ml for IL-1b, 8 pg/ml for IL-6 and 30 pg/ml for
TGF-b1. The intra- and inter-assay coefﬁcients of variation
were less than 5% for all immunoassays.
ALP ASSAY
ALP activity was quantiﬁed in the cellular fraction of the
osteoblasts culture. Cell extract (50 ml) was incubated with
100 ml of p-nitrophenylphosphate (liquid p-NPP, ready to
use, KEM-EN-TEC, Kobenhavn, Denmark). In the presence
of ALP, p-NPP is transformed to p-nitrophenol and in-
organic phosphate. p-Nitrophenol absorbance is measured
at 405 nm after 10 min of incubation at 37(C. A standard
preparation of p-nitrophenol was used for calibration.
Results were expressed in nanomoles of p-nitrophenol
released per min and per mg of DNA.
QUANTITATIVE REAL-TIME RT-PCR
RNA from 3! 106 cells was isolated by SV total RNA
isolation system (Promega, Leiden, The Netherlands). RNA
(0.5 mg) was reverse transcribed in 30 ml buffer containing
10 mM DTT, 1 mM dNTPs, 500 ng (dT)15 primer, 140 U M-
MLV Reverse Transcriptase and 40 U RNaseOUT (Life
Technologies, Merelbeke, Belgium) for 60 min at 37(C. The
reaction was stopped by incubating the samples at 95(C for
5 min and by adding 100 ml of H2O. Polymerase chain
reaction (PCR) was performed by using the LightCycler-
FastStart DNA Master Sybr Green I (Roche Diagnostics,
Brussels, Belgium). The PCR template source was either
3 ng ﬁrst-strand cDNA or puriﬁed DNA standard. Primer
sequences used to amplify the desired cDNA are as
follows: glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) forward and reverse primers: 5#-
TTGGTATCGTGGAAGGACTCA-3# and 5#-TGTCATCA
TATTTGGCAG GTTT-3#; AGG forward and reverse pri-
mers: 5#-GCACCATGCCTTCTGCTTCCGAG-3# and 5#-
CTCCACTGCCTGTGAAGTCACCAC-3#; MMP-3 forward
and reverse primers: 5#-ATGAGGTACGAGCTGG-3# and
5#-TCACGCTCAAGTTCCC-3#; MMP-13 forward and re-
verse primers: 5#-CAACGGACCCATACAG-3# and 5#-
ACAGACCATGTGTCCC-3#. Ampliﬁcation was performed
with a spectroﬂuorometric thermal cycler (LightCycler,
Roche Diagnostics, Brussels, Belgium). For each gene
under study, a standard curve was generated from puriﬁed
cDNA of the gene concerned ranging from 106 to 10 copies.
The efﬁciency of reverse transcription is similar for one
particular messenger in all our culture conditions, so we can
state that the cDNA levels reﬂect the mRNA levels for the
concerned gene. To standardize mRNA levels, we ampli-
ﬁed GAPDH, a house keeping gene, as an internal control.
Gene expression was normalized by calculating the ratio
982 C. Sanchez et al.: Ob-induced chondrocyte metabolism dysregulationbetween the number of cDNA copies of AGG, MMP-3,
MMP-13, and that of GAPDH. After ampliﬁcation, a ﬁnal
melting curve was recorded by cooling the PCR mixture to
65(C for 30 s and then slowly heating it to 95(C at 0.1(/s.
Fluorescence was measured continuously during the slow
temperature rise to monitor the dissociation of dsDNA.
Speciﬁcity of the expected LightCycler products was
demonstrated by melting curve analysis. Ampliﬁcation
products performed in the LightCycler were checked by
electrophoresis on 1.5% ethidium bromide stained agarose
gel. The estimated size of the ampliﬁed fragments matched
the calculated size.
CALCULATION AND STATISTICAL ANALYSIS
The results (meanG S.E.M.) were expressed as sum of the
concentration of AGG found in the culture supernatant, CM
and FRM per mg of DNA, or as GADPH-normalized gene
expression. A multivariate repeated measures ANOVA
model with calculation of contrasts was performed on all
the experiments.
Results
INFLUENCE OF OA OSTEOBLASTS PHENOTYPE
ON HUMAN CHONDROCYTE METABOLISM
In comparison with N zones isolated osteoblasts, SC
subchondral OA osteoblasts in monolayer produced higher
amounts of ALP (C95%), OC (C98%), IL-6 (C134%) and
TGF-b1 (C41%) whereas IL-1b concentration was similar
(Table I). These ﬁndings indicate that SC osteoblasts had
an altered phenotype. We have then cultured N or SC
osteoblasts in monolayer with OA chondrocytes in alginate
beads. In parallel, skin ﬁbroblasts in monolayer and
chondrocytes in alginate beads were co-cultured as
a control condition. At the beginning of the co-culture
period, 3.5G 0.5 mg of DNA was measured in alginate
beads, osteoblasts and ﬁbroblasts monolayer culture,
indicating that a similar number of chondrocytes, osteo-
blasts or ﬁbroblasts were introduced in the co-culture
model. Further, co-culture conditions did not signiﬁcantlymodify DNA content in the different compartments of the co-
culture, demonstrating that cell number remained stable
over the co-culture period (data not shown).
When they are cultured alone (mono-culture), human OA
chondrocytes in alginate beads spontaneously produced
8.5 mg of AGG per mg of DNA. As previously described,
newly-synthesized AGG were essentially accumulated in
alginate bead26. Seventy-three percent was found in the
FRM, 26% in the CM and only 1% was released in the
supernatant. When alginate beads were co-cultured with
SC osteoblasts, AGG content in alginate bead was
decreased by 27G 7% (P! 0.001) whereas N osteoblasts
or normal skin ﬁbroblasts did not modify AGG content
signiﬁcantly [Fig. 2(A)]. The decrease of AGG content was
signiﬁcantly more marked in the CM compartment of
alginate bead than in FRM. AGG content was decreased
by 45G 8% in CM (P! 0.01), but only by 20G 7% in FRM
(P! 0.05). The ratio of AGG released into the supernatant
was unchanged in co-culture (data not shown). In mono-
culture, OA chondrocytes in alginate beads spontaneously
expressed a mean value of 22 copies of AGG per 1000
copies of GAPDH. When they were co-cultured with
osteoblasts, AGG mRNA level in chondrocytes was
signiﬁcantly reduced by SC (P! 0.001) but not signiﬁcantly
by N osteoblasts [Fig. 2(B)].
In mono-culture, OA chondrocytes in alginate beads
spontaneously secreted a mean value of 752 ng of MMP-3
per mg DNA and expressed a mean value of 1400 copies of
MMP-3 and 5 copies of MMP-13 per 1000 copies of GAPDH.
In co-culture with SC osteoblasts, MMP-3 production and
MMP-3 and -13 mRNA levels in chondrocytes were
signiﬁcantly increased by 1.6, 1.65 and 2 times, respectively
(P! 0.001). In comparison, N osteoblasts or skin ﬁbroblasts
did not modify MMP-3 production or mRNA level but
decreased that of MMP-13 mRNA (P! 0.01) (Fig. 3).
EFFECTS OF PRE-TREATMENT OF OSTEOBLASTS WITH IL-1b
ON HUMAN CHONDROCYTE METABOLISM
IL-1b (1.7 ng/ml) signiﬁcantly stimulated ALP and IL-6
(0.01O PO 0.001) production, but inhibited those of OC
and TGF-b1 (P! 0.001) in both N and SC osteoblasts in
monolayer (Table I). IL-1-treated osteoblasts were thenTable I
Effects of IL-1b, IL-6 or OSM on human subchondral osteoblasts in monolayer
Control IL-1b IL-6/IL-6sR OSM
DNA (mg/wells) N 3.1G 0.5 3.0G 0.6 3.5G 0.3 3.2G 0.4
SC 3.3G 0.3 3.1G 0.4 3.6G 0.4 3.5G 0.3
ALP ((nmol/mg DNA)/min) N 9.1G 0.6 12.2G 0.4** 10.9G 1.5 14.3G 0.6***
SC 17.8G 0.6### 23.5G 1.2*** 17.7G 1.2 27.6G 4.3***
OC (ng/mg DNA) N 6.8G 0.3 1.9G 0.1*** 3.3G 0.1*** 2.6G 0.7***
SC 13.5G 0.4### 3.4G 1.0*** 6.5G 0.8*** 5.3G 0.5***
IL-1b (pg/mg DNA) N 4.4G 0.6 N.D. 5.1G 0.3 5.1G 1.1
SC 4.5G 0.7 N.D. 6.3G 0.7 5.1G 1.0
IL-6 (pg/mg DNA) N 595G 35 3745G 80*** N.D. 2946G 28***
SC 1397G 114### 4620G 73*** N.D. 3690G 104***
TGF-b1 (pg/mg DNA) N 37.5G 0.5 29.6G 2.5*** 62.6G 5.5*** 46.0G 2.1**
SC 52.9G 3.4### 38.4G 3.3*** 71.9G 5.2** 60.7G 3.2
Values are meansG S.E.M. (nZ 9) of three independent cultures performed with subchondral osteoblasts coming from three different
donors. Subchondral osteoblasts were cultured in the presence of 1.7 ng/ml IL-1b, 100 ng/ml IL-6, 50 ng/ml IL-6sR or 10 ng/ml OSM during
72 h. Statistical signiﬁcance between N and SC subchondral osteoblasts: ###P! 0.001 or between controls and cytokine-stimulated
osteoblasts: **P! 0.01 and ***P! 0.001.
983Osteoarthritis and Cartilage Vol. 13, No. 11Fig. 2. AGG content in alginate beads (A) and AGG gene expression by chondrocytes (B) after 4 days of culture in the absence (mono-culture)
or in the presence (co-culture) of osteoblasts isolated from SC or N zones of subchondral bone. Before co-culture, human osteoblasts were
incubated or not (control) for 72 h with IL-1b (1.7 ng/ml), IL-6 (100 ng/ml in combination with 50 ng/ml of IL-6sR), or OSM (10 ng/ml). As
a control, human OA chondrocytes in alginate beads were also co-cultured with normal human skin ﬁbroblasts. The results are expressed as
the meanG S.E.M. of three experiments performed with cells coming from three different donors. Comparison of mean values of total AGG
production (A) or GAPDH mRNA normalized AGG mRNA copies (numbers of mRNA gene copies per 1000 GAPDH mRNA copies, B) was
performed by repeated measures ANOVA analysis. Statistical signiﬁcances: chondrocytes/osteoblasts co-culture compared to mono-culture
***P! 0.001; pre-treated osteoblasts compared to the controls ^P! 0.05, ^^P! 0.01, ^^^P! 0.001; SC osteoblasts compared to N
osteoblasts #P! 0.05, ##P! 0.01 and ###P! 0.001.cultured together with chondrocytes in alginate beads.
Whilst N osteoblasts had no effect on AGG synthesis, IL-
1b-treated N osteoblasts decreased AGG content in
alginate beads and AGG gene expression in similar order
to that of SC osteoblasts (P! 0.01, Fig. 2). Pre-treatment of
SC osteoblasts with IL-1b signiﬁcantly accentuated their
inhibitory effect on AGG synthesis by chondrocytes
(P! 0.05, Fig. 2). In comparison with untreated N
osteoblasts, IL-1b-treated N osteoblasts induced a signiﬁ-
cant elevation of MMP-3 and MMP-13 mRNA levels in
chondrocytes (P! 0.001, Fig. 3). IL-1b treatment also
enhanced the stimulating effect of SC osteoblasts on MMPs
gene expression (Fig. 3).EFFECTS OF PRE-TREATMENT OF OSTEOBLASTS
WITH IL-6/IL-6SR ON HUMAN CHONDROCYTE METABOLISM
In both N and SC osteoblasts monolayer culture, IL-6
(100 ng/ml) in the presence of its soluble receptor (IL-6sR)
signiﬁcantly decreased OC and increased TGF-b1
(P! 0.001) production, but did not signiﬁcantly modify
ALP and IL-1b synthesis (Table I). IL-6/IL-6sR-treated
osteoblasts were then cultured together with chondrocytes
in alginate beads. Whilst N osteoblasts had no effect on
AGG synthesis, IL-6/IL-6sR-treated N osteoblasts de-
creased AGG content in alginate beads and AGG gene
expression in the same order of magnitude as OA
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osteoblasts with IL-6/IL-6sR did not increase their inhibitory
effect on AGG synthesis by chondrocytes (Fig. 2). In
comparison with untreated N osteoblasts, IL-6-treated N
osteoblasts induced a signiﬁcant elevation of MMP-3 and
MMP-13 mRNA levels in chondrocytes (P! 0.001, Fig. 3).
IL-6 treatment signiﬁcantly enhanced the stimulating effect
of SC osteoblasts on MMP-13 synthesis (P! 0.05) but
did not modify the stimulating effect of SC osteoblasts on
MMP-3 (Fig. 3).
EFFECTS OF PRE-TREATMENT OF OSTEOBLASTS WITH OSM
ON HUMAN CHONDROCYTE METABOLISM
In both N and SC osteoblasts in monolayer, OSM (10 ng/
ml) signiﬁcantly inhibited OC but stimulated ALP and IL-6
(P! 0.001) production. OSM did not signiﬁcantly modify IL-
1b production. It also increased TGF-b1 synthesis but only
in N osteoblasts culture (P! 0.01) (Table I). OSM-treated
osteoblasts were then co-cultured for 4 days with chon-
drocytes in alginate beads. Whilst N osteoblasts had no
effect on AGG synthesis, OSM-treated N osteoblasts
decreased AGG content in alginate beads and AGG gene
expression in the same order of magnitude as SC
osteoblasts (P! 0.001, Fig. 2). Pre-treatment of SC
osteoblasts with OSM did not accentuate their inhibitory
effect on AGG synthesis by chondrocytes (Fig. 2). By
comparison with untreated N osteoblasts, OSM-treated N
osteoblasts induced a signiﬁcant elevation of MMP-3 and
MMP-13 mRNA levels in chondrocytes (P! 0.05 and
P! 0.001, respectively, Fig. 3). OSM treatment also
enhanced the stimulating effect of SC osteoblasts on
MMP-13 gene expression (Fig. 3), but had no effect on
MMP-3.
Discussion
Recent evidences suggest a key role for subchondral bone
tissue in the pathogenesis of OA, possibly via the production
of cytokines and growth factors. Using bone explants from
OA patients, number of investigators have previously shown
that these explants contain more TGF-b and IGF compared
with normal bone tissues27,28. Herein, we have observed that
SC osteoblasts secreted more ALP, OC, IL-6 and TGF-b1
than cells isolated from N zones of subchondral bone,
corroborating the Lajeunesse’s group results2,5. This ﬁnding
indicates that OA subchondral osteoblasts used in this study
show an altered phenotype compared to N cells and that they
secrete mediators, such as TGF-b1 and IL-6, involved in the
structural changes of OA cartilage29e32. As previous
pathological studies have shown the presence of micro-
cracks in the tidemark that appear early in OA6, we
have speculated that soluble mediators produced by SCosteoblasts could modulate chondrocyte metabolism and
contribute to cartilage degradation. To verify this hypothesis,
we have developed an original model of culture in which
human osteoblasts from the SC subchondral bone and OA
chondrocytes are cultured in the same environment, but
without any contact. In parallel, we have tested the effects of
three cytokines on the osteoblasts phenotype. These three
cytokines have been chosen because there is a body of
evidence suggesting that thesemediators are involved in the
communication between osteoclasts, bonemarrow cells and
osteoblasts. Further, these cytokines have been shown to
inﬂuence bone remodeling and therefore, could be involved
in subchondral bone sclerosis.
The originality of our model lies in the fact that we use
osteoblasts from the SC subchondral bone and that OA
chondrocytes are cultured in alginate beads. In a previous
work, Westacott et al.10 have demonstrated that OA
trabecular osteoblasts in monolayer degraded cartilage
explants in about half of the cases. A key element in
cartilage degradation is an increase in metalloproteinase
activities. MMP-3 and MMP-13 are two MMPs of particular
importance in the degradation of cartilage in OA, because
these MMPs are highly expressed by OA chondrocytes
compared to normal cells. MMP-3 cleaves a wide variety
of matrix macromolecules, e.g., proteoglycan, ﬁbronectin
and several collagens whereas MMP-13 is the most active
collagenase to degrade type II collagen network. It has
been shown to be 5e10 folds more active on type II
collagen than MMP-1 and MMP-833. Interestingly, we
demonstrate that OA osteoblasts induced a strong eleva-
tion of MMP-3 and MMP-13 gene expression and MMP-3
secretion whereas N osteoblasts or normal skin ﬁbroblasts
have no effect. This observation indicates that osteoblast-
induced MMPs production is related to its particular OA
phenotype. These data suggest that SC osteoblasts could
potentially contribute to cartilage degradation if activation
were to occur in vivo. Indeed, we have not detected MMP
activity estimated by caseineresoruﬁn and 3H-collagen
degradation tests in co-culture supernatants, suggesting
that newly-synthesized proMMPs were not processed in
active MMPs in our model. This data must be paralleled
with those reported by Westacott et al., showing that OA
osteoblasts-induced cartilage explants degradation. A
potential candidate responsible for this MMPs induction
could be the hepatocyte growth factor (HGF), found in the
deep layer of OA cartilage and recently found to be
produced by OA subchondral osteoblasts and not by
chondrocytes themselves9. HGF is a growth factor known
to induce the expression of MMP-13 in vitro by OA
chondrocytes34. Beside this stimulating effect of SC OA
osteoblasts on MMPs synthesis, we have also observed
that AGG content in alginate beads decreases when
chondrocytes are co-cultured with SC osteoblasts. Again,
this effect seems to be related to SC phenotype ofFig. 3. MMP-3 production in the culture supernatant (A) and MMP-3 (B) and -13 (C) gene expressions by human OA chondrocytes in alginate
beads after 4 days of culture in the absence (mono-culture) or in the presence (co-culture) of osteoblasts isolated from SC or N zones of
subchondral bone. Before co-culture, human osteoblasts were either incubated or not (control) for 72 h with IL-1b (1.7 ng/ml), IL-6 (100 ng/ml
in combination with 50 ng/ml of IL-6sR), or OSM (10 ng/ml). As a control, human OA chondrocytes in alginate beads were also co-cultured
with normal human skin ﬁbroblasts. The results are expressed as the meanG S.E.M. of three experiments performed with cells coming from
three different donors. The mRNA copy numbers were normalized against the corresponding copy number of GAPDH mRNA and expressed
in numbers of mRNA gene copies per 1000 GAPDH mRNA copies. Comparison of mean values was performed by repeated measures
ANOVA analysis. Statistical signiﬁcances: chondrocytes/osteoblasts co-culture compared to mono-culture **P! 0.01, ***P! 0.001; pre-
treated osteoblasts compared to the controls ^P! 0.05, ^^^P! 0.001; SC osteoblasts compared to N osteoblasts ##P! 0.01,
###P! 0.001.
986 C. Sanchez et al.: Ob-induced chondrocyte metabolism dysregulationosteoblasts as suggested by the absence of effect of N
osteoblasts and ﬁbroblasts. SC osteoblasts also induce
a decrease of AGG mRNA level in chondrocytes, in-
dicating that the decrease of AGG content results in
a decrease of AGG synthesis. Among the factors
stimulating MMP synthesis and inhibiting AGG synthesis,
IL-1b is probably one of the most powerful. Nevertheless,
in our experimental conditions, SC and N osteoblasts
produce similar amounts of IL-1b, indicating that the
overproduction of MMPs by chondrocytes does not result
in an increase of IL-1b concentration. Also, the IL-1b
quantities found in the 4 days co-culture supernatant were
below the detection limit of our EASIA assay (10 pg/ml,
data not shown), even in the co-culture with IL-1b-
stimulated osteoblasts. Nevertheless, we cannot exclude
other mechanisms including an increase of OA chondro-
cytes sensitivity to IL-1b, as a consequence of an
overexpression of IL-1 receptors at its membrane level,
and/or an increase of IL-1b bioactivity secondary to
a decrease of the synthesis of the natural receptor
antagonist (IL-1Ra). Another potential candidate could be
IL-6 that is overproduced by OA osteoblasts. In a previous
study, we have reported that IL-6 stimulated MMP-3 but
inhibited AGG production by human OA chondrocytes in
alginate beads32. In addition, Flannery et al.35 have
observed that IL-6 and/or IL-6sR increased AGG catabo-
lism above that seen in the presence of IL-1a alone,
suggesting that IL-6 acts in synergy with IL-1 to degrade
cartilage. Nevertheless, we are aware that our study
fails to clearly identify the mediator(s) responsible for
the OA osteoblasts-induced dysregulation of chondrocyte
metabolism. Future investigations have been planed
in which neutralizing antibodies against cytokines, inhib-
itors of cyclooxygenases or nitric oxide synthase will be
used.
Another hypothesis is that IL-1b, IL-6 and OSM which are
overproduced by OA chondrocytes could modulate sub-
chondral osteoblasts creating a physiopathological loop
between cartilage and subchondral bone. Of interest is the
observation that IL-1b, IL-6 and OSM modulate N osteo-
blasts phenotype and induce an increase of ALP and
a decrease of OC. Interestingly, the cytokine-modiﬁed
osteoblasts phenotype is different to that of SC osteoblasts.
In comparison to N osteoblasts, SC osteoblasts produce
more ALP and OC while cytokine-treated osteoblasts
produce more ALP but less OC. This observation suggests
that osteoblasts acquired SC phenotype does not only
result from IL-1b, IL-6 or OSM activities and that probably
other mechanical and/or biochemical factors (e.g., tumor
necrosis factor alpha, bone morphogenetic proteins) are
involved36,37. However, cytokine-treated N osteoblasts
decrease AGG synthesis and increase MMPs production
by chondrocytes, in the same order of magnitude as SC
osteoblasts. This ﬁnding indicates that SC osteoblasts
effects on cartilage can be mimicked by stimulating N
osteoblasts by one of these cytokines. However, IL-1b, IL-6
and OSM have different effects on N osteoblasts. One of
the major difference concerns the production of TGF-b1.
Whilst IL-1b decreases TGF-b production by N osteoblasts,
IL-6 and OSM increase it. This observation suggests that
probably TGF-b1 does not play a major role in osteoblasts-
induced cartilage metabolic dysfunction.
In summary, our work demonstrated that the SC
phenotype of osteoblasts induces a marked dysregulation
of chondrocyte metabolism, characterized by a decrease of
AGG synthesis and an increase of proMMPs synthesis.
These ﬁndings suggest that osteoblasts from the SCsubchondral bone, besides synoviocytes, may contribute
to OA physiopathology.
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